| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
| Description | CD19 molecule | |||||
| GTO ID | GTC2793 |
| Trial ID | NCT05054257 |
| Disease | Non-Hodgkin's Lymphoma | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CART19 Cells Effects in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma |
| Year | 2021 |
| Country | Czechia |
| Company sponsor | Institute of Hematology and Blood Transfusion, Czech Republic |
| Other ID(s) | UHKT-CAR19-01|2018-004789-32 |
| Cohort 1 | |||||||||
|
|||||||||